Kairos Pharma Ltd. (KAPA)
1.73
-0.08
(-4.42%)
USD |
NYAM |
Sep 18, 16:00
1.75
+0.02
(+1.16%)
After-Hours: 20:00
Kairos Pharma Price to Book Value : 1.263 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 1.263 |
| September 17, 2026 | 1.322 |
| September 16, 2026 | 1.322 |
| September 15, 2026 | 1.351 |
| September 14, 2026 | 1.344 |
| September 11, 2026 | 1.284 |
| September 10, 2026 | 1.227 |
| September 09, 2026 | 1.212 |
| September 08, 2026 | 1.293 |
| September 04, 2026 | 1.344 |
| September 03, 2026 | 1.220 |
| September 02, 2026 | 1.154 |
| September 01, 2026 | 1.205 |
| August 31, 2026 | 1.227 |
| August 28, 2026 | 1.212 |
| August 27, 2026 | 1.232 |
| August 26, 2026 | 1.329 |
| August 25, 2026 | 1.269 |
| August 24, 2026 | 1.186 |
| August 21, 2026 | 1.482 |
| August 20, 2026 | 1.508 |
| August 19, 2026 | 1.583 |
| August 18, 2026 | 1.586 |
| August 17, 2026 | 1.659 |
| August 14, 2026 | 1.743 |
| Date | Value |
|---|---|
| August 13, 2026 | 1.840 |
| August 12, 2026 | 1.813 |
| August 11, 2026 | 1.858 |
| August 10, 2026 | 1.789 |
| August 07, 2026 | 1.973 |
| August 06, 2026 | 1.994 |
| August 05, 2026 | 1.687 |
| August 04, 2026 | 1.662 |
| August 03, 2026 | 1.585 |
| July 31, 2026 | 1.565 |
| July 30, 2026 | 1.533 |
| July 29, 2026 | 1.528 |
| July 28, 2026 | 1.574 |
| July 27, 2026 | 1.584 |
| July 24, 2026 | 1.457 |
| July 23, 2026 | 1.523 |
| July 22, 2026 | 1.598 |
| July 21, 2026 | 1.83 |
| July 20, 2026 | 1.645 |
| July 17, 2026 | 1.585 |
| July 16, 2026 | 1.738 |
| July 15, 2026 | 1.626 |
| July 14, 2026 | 1.738 |
| July 13, 2026 | 1.727 |
| July 10, 2026 | 1.803 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.595 |
| Alnylam Pharmaceuticals, Inc. | 23.66 |
| Anika Therapeutics, Inc. | 2.029 |
| Savara, Inc. | 7.678 |
| Vericel Corp. | 5.534 |
Price to Book Value Related Metrics
| Price | 1.73 |
| Earnings Yield | -112.6% |
| Market Cap | 5.295M |